Related references
Note: Only part of the references are listed.Species Differences of Bile Acid Redox Metabolism: Tertiary Oxidation of Deoxycholate is Conserved in Preclinical Animals
Qiuhong Lin et al.
DRUG METABOLISM AND DISPOSITION (2020)
Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity
Yu-Jie Chen et al.
DRUG METABOLISM AND DISPOSITION (2019)
Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds
Sangwoo Ryu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Origin and Spread of Evolving Artemisinin-Resistant Plasmodium falciparum Malarial Parasites in Southeast Asia
Matthew R. Hassett et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers
Huixiang Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Species differences in bile acids II. Bile acid metabolism
Rhishikesh Thakare et al.
JOURNAL OF APPLIED TOXICOLOGY (2018)
Inhibition of CYP3A by Antimalarial Piperaquine and Its Metabolites in Human Liver Microsomes With IVIV Extrapolation
Mohd Yusmaidie Aziz et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
F. Joel Leong et al.
MALARIA JOURNAL (2018)
Metabolite identification of the antimalarial piperaquine in vivo using liquid chromatography-high-resolution mass spectrometry in combination with multiple data-mining tools in tandem
Aijuan Yang et al.
BIOMEDICAL CHROMATOGRAPHY (2016)
Metabolism of dictamnine in liver microsomes from mouse, rat, dog, monkey, and human
Pei Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′ -OH-bupropion in vitro
Jennifer E. Sager et al.
DRUG METABOLISM AND DISPOSITION (2016)
CYP3A Specifically Catalyzes 1β-Hydroxylation of Deoxycholic Acid: Characterization and Enzymatic Synthesis of a Potential Novel Urinary Biomarker for CYP3A Activity
Martin A. Hayes et al.
DRUG METABOLISM AND DISPOSITION (2016)
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals
Slobodan Rendic et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Quantitative ADME Proteomics - CYP and UGT Enzymes in the Beagle Dog Liver and Intestine
Aki T. Heikkinen et al.
PHARMACEUTICAL RESEARCH (2015)
Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects
Sreeneeranj Kasichayanula et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance
K-H Shin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Evaluation of P450 Inhibition and Induction by Artemisinin Antimalarials in Human Liver Microsomes and Primary Human Hepatocytes
Jie Xing et al.
DRUG METABOLISM AND DISPOSITION (2012)
Catalytic versus Inhibitory Promiscuity in Cytochrome P450s: Implications for Evolution of New Function
Robert S. Foti et al.
BIOCHEMISTRY (2011)
4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Ulf Diczfalusy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Current Cytochrome P450 Phenotyping Methods Applied to Metabolic Drug-Drug Interaction Prediction in Dogs
Beth Miskimins Mills et al.
DRUG METABOLISM AND DISPOSITION (2010)
Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity
Ursula Lutz et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion
K. Sandy Pang et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase
Charles W. Locuson et al.
DRUG METABOLISM AND DISPOSITION (2009)
Prediction of human pharmacokinetics - gut-wall metabolism
Urban Fagerholm
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry
MM Kushnir et al.
CLINICAL BIOCHEMISTRY (2004)
Urinary 6β-hydroxycortisol:: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals
MM Galteau et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes P450: Role of CYP3A4 and CYP3A5
KC Patki et al.
DRUG METABOLISM AND DISPOSITION (2003)
In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs
RA Graham et al.
DRUG METABOLISM AND DISPOSITION (2002)
Effect of multiple dosing of ketoconazole on pharmacokinetics of midazolam, a cytochrome P-450 3A substrate in beagle dogs
M Kuroha et al.
DRUG METABOLISM AND DISPOSITION (2002)
Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans -: Evidence for involvement of cytochrome P450 3A4
K Bodin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Erythromycin breath test
LP Rivory et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs
Y Kyokawa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2001)
Share Paper
